ISSN (Online) : 2277-4572
Author(s): Devulapally Anuradha*
The disease Amavata is the most common crippling and disabling disorder. The clinical research on Amavata has been under taken at different centers. Drugs are available to ameliorate the symptoms of inflammation in the form of NSAIDS (Non-steroidal anti inflammatory drugs) and long term suppression is achieved by DMARDS(Disease modifying anti rheumatic drugs). But most of them have gastro intestinal side effects and toxicity. Sunti and vrudhadarumoola churnas are very effective in pacifying digestive disorders simultaneously relieving pain. Amavata is a global problem which is increasing with the change of dietary habits, social structure and life style. The objective of this study is to find a cost-effective remedy to Amavata. Hence Sunti and Vrudhadaru churnas are selected for a comparative study of their efficacy in Amavata management. 30 patients were selected between 20-30 years of age out of whom 15 patients were taken for clinical trial with Suntichurna under group‘A’ and the remaining 15 patients were taken for clinical trials with Vrudhadarumoolachurna under group ‘B’. The laboratory investigations were done before and after treatment. Prepared churnas of 500gms each were given, thrice daily, with lukewarm water after light meal for 21 days. The drugs Sunti and Vrudhadaru churna showed encouraging results as the drugs are having deepana, and panchana karmas which improves agni and amapachana. During treatment no side effects were noted. The aim of treatment is to prevent the production of ama and to improve pachana at dhatu level. Both the drugs were found to be effective in relieving the symptoms of Amavata thus fulfilling the aim.
